Your browser doesn't support javascript.
loading
Interleukin-17 induces hypertension but does not impair cerebrovascular function in pregnant rats.
Duncan, Jeremy W; Nemeth, Zoltan; Hildebrandt, Emily; Granger, Joey P; Ryan, Michael J; Drummond, Heather A.
Afiliação
  • Duncan JW; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA.
  • Nemeth Z; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA.
  • Hildebrandt E; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA.
  • Granger JP; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA.
  • Ryan MJ; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA.
  • Drummond HA; Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39206, USA. Electronic address: hdrummond@umc.edu.
Pregnancy Hypertens ; 24: 50-57, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33677419
ABSTRACT
Preeclampsia affects 5-8% of pregnancies and is characterized by hypertension, placental ischemia, neurological impairment, and an increase in circulating inflammatory cytokines, including Interleukin-17 (IL17). While placental ischemia has also been shown to impair cerebrovascular function, it is not known which placental-associated factor(s) drive this effect. The purpose of this study was to examine the effects of IL17 on cerebrovascular function during pregnancy. To achieve this goal, pregnant rats were infused with either IL17 (150 pg/day, 5 days, osmotic minipump), or vehicle (saline/0.7% BSA osmotic minipump) starting at gestational day (GD) 14. On GD 19, the cerebral blood flow (CBF) response to increases in mean arterial pressure (MAP) was measured in vivo, and myogenic constrictor responses of the middle cerebral artery (MCA) were assessed ex vivo. IL17 increased MAP but impaired CBF responses only at the highest arterial pressure measured (190 mmHg). Myogenic constrictor responses overall were mostly unaffected by IL17 infusion; however, the intraluminal pressure at which peak myogenic tone was generated was lower in the IL17 infused group (120 vs 165 mm Hg), suggesting maximal tone is exerted at lower intraluminal pressures in IL17-treated pregnant rats. Consistent with the lack of substantial change in overall myogenic responsiveness, there was no difference in cerebral vessel expression of putative mechanosensitive protein ßENaC, but a tendency towards a decrease in ASIC2 (p = 0.067) in IL17 rats. This study suggests that infusion of IL17 independent of other placental ischemia-associated factors is insufficient to recapitulate the features of impaired cerebrovascular function during placental ischemia. Further studies to examine of the role of other pro-inflammatory cytokines, individually or a combination, are necessary to determine mechanisms of cerebral vascular dysfunction during preeclampsia.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Circulação Cerebrovascular / Interleucina-17 / Artéria Cerebral Média / Hipertensão Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pré-Eclâmpsia / Circulação Cerebrovascular / Interleucina-17 / Artéria Cerebral Média / Hipertensão Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Ano de publicação: 2021 Tipo de documento: Article